Summit Trail Advisors, LLC Pacira Bio Sciences, Inc. Transaction History

Summit Trail Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 10, 2018	SELL	$27.5 - $39.8 $415,332 - $601,099	-15,103 Closed	0 $0
Q1 2018 May 22, 2018	SELL	$29.98 - $46.35 $11.5 Million - $17.8 Million	-384,585 Reduced 96.22%	15,103 $400,000
Q1 2018 May 21, 2018	BUY	$29.98 - $46.35 $11.6 Million - $17.9 Million	386,313 Added 2888.32%	399,688 $400,000
Q4 2017 Feb 14, 2018	BUY	$31.85 - $46.95 $425,993 - $627,956	13,375	13,375 $531,000

260

48.9M

118K

63.7K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.09B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit Trail Advisors, LLC with notifications on news.